BioScience Health Innovations, Inc.
BHIC
$4.49
$0.4912.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.49M | 5.21M | 5.69M | 4.73M | 4.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.49M | 5.21M | 5.69M | 4.73M | 4.17M |
| Cost of Revenue | 2.08M | 2.38M | 2.45M | 1.72M | 1.43M |
| Gross Profit | 2.42M | 2.83M | 3.24M | 3.01M | 2.73M |
| SG&A Expenses | 3.03M | 2.77M | 2.52M | 2.12M | 1.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.10M | 5.15M | 4.97M | 3.84M | 3.22M |
| Operating Income | -613.30K | 62.30K | 719.00K | 885.70K | 950.70K |
| Income Before Tax | -613.30K | 62.30K | 719.00K | 885.70K | 950.70K |
| Income Tax Expenses | 44.90K | 77.00K | 77.00K | -- | -- |
| Earnings from Continuing Operations | -0.66 | -0.01 | 0.64 | 0.89 | 0.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -658.10K | -14.60K | 642.10K | 885.70K | 950.70K |
| EBIT | -613.30K | 62.30K | 719.00K | 885.70K | 950.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.06 | 0.00 | 0.03 | 0.05 | 0.06 |
| Normalized Basic EPS | -0.03 | 0.00 | 0.02 | 0.03 | 0.04 |
| EPS Diluted | -0.06 | 0.00 | 0.03 | 0.05 | 0.06 |
| Normalized Diluted EPS | -0.03 | 0.00 | 0.02 | 0.03 | 0.03 |
| Average Basic Shares Outstanding | 45.02M | 44.31M | 76.85M | 76.65M | 76.15M |
| Average Diluted Shares Outstanding | 45.02M | 44.73M | 77.69M | 77.91M | 77.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |